Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study-Reference-Cited by-同舟云学术

Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study

Published:2010-06-08 Issue:10 Volume:26 Page:773-779
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Facchinetti Fabio,Allais Gianni,Nappi Rossella E.,Gabellari Ilaria Castagnoli,Di Renzo Gian Carlo,Genazzani Andrea R.,Bellafronte Manuela,Roncolato Maurizio,Benedetto Chiara

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2010.487607

Reference18 articles.

1. Migraine prevalence, disease burden, and the need for preventive therapy

2. Migraine in Women

3. Menstrual Migraine: Pathophysiology, Diagnosis, and Impact

4. Menstrual migraine: a clinical review

5. A Report on the Journal 2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Menstrually associated migraine;Handbook of Clinical Neurology;2024

2. Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?;Expert Review of Neurotherapeutics;2023-04-03

3. Current and emerging pharmacotherapy for menstrual migraine: a narrative review;Expert Opinion on Pharmacotherapy;2023-03-23

4. Validation of diagnostic ICHD-3 criteria for menstrual migraine;Cephalalgia;2022-05-06

5. Acute and Preventive Management of Migraine during Menstruation and Menopause;Journal of Clinical Medicine;2021-05-24